Loading...

Mary Feng, MD

Title(s)Professor, Radiation Oncology
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Stanford University, Stanford, CABS06/1997Biological Sciences
    University of Michigan, Ann Arbor, MI06/2007Radiation Oncology

    Collapse ORNG Applications 
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Wilkie JR, Mierzwa ML, Yao J, Eisbruch A, Feng M, Weyburne G, Chen X, Holevinski L, Mayo CS. Big data analysis of associations between patient reported outcomes, observer reported toxicities, and overall quality of life in head and neck cancer patients treated with radiation therapy. Radiother Oncol. 2019 May 22; 137:167-174. PMID: 31128357.
      View in: PubMed
    2. Xu MJ, Feng M. Radiation Therapy in HCC: What Data Exist and What Data Do We Need to Incorporate into Guidelines? Semin Liver Dis. 2019 Feb; 39(1):43-52. PMID: 30536291.
      View in: PubMed
    3. Yu Y, Feng M. Radiotherapy for Hepatocellular Carcinoma. Semin Radiat Oncol. 2018 10; 28(4):277-287. PMID: 30309638.
      View in: PubMed
    4. Matuszak MM, Fuller CD, Yock TI, Hess CB, McNutt T, Jolly S, Gabriel P, Mayo CS, Thor M, Caissie A, Rao A, Owen D, Smith W, Palta J, Kapoor R, Hayman J, Waddle M, Rosenstein B, Miller R, Choi S, Moreno A, Herman J, Feng M. Performance/outcomes data and physician process challenges for practical big data efforts in radiation oncology. Med Phys. 2018 Oct; 45(10):e811-e819. PMID: 30229946.
      View in: PubMed
    5. Pollom EL, Feng M, Chang DT. Comparing Modalities Using the National Cancer Database: Concerns With Rajyaguru et al. J Clin Oncol. 2018 Aug 20; 36(24):2557. PMID: 29945518.
      View in: PubMed
    6. Parikh ND, Marshall VD, Green M, Lawrence TS, Razumilava N, Owen D, Singal AG, Feng M. Effectiveness and cost of radiofrequency ablation and stereotactic body radiotherapy for treatment of early-stage hepatocellular carcinoma: An analysis of SEER-medicare. J Med Imaging Radiat Oncol. 2018 Oct; 62(5):673-681. PMID: 29877615.
      View in: PubMed
    7. Maimela E, Alberts M, Bastiaens H, Fraeyman J, Meulemans H, Wens J, Van Geertruyden JP. Interventions for improving management of chronic non-communicable diseases in Dikgale, a rural area in Limpopo Province, South Africa. BMC Health Serv Res. 2018 05 04; 18(1):331. PMID: 29728147.
      View in: PubMed
    8. Simeth J, Johansson A, Owen D, Cuneo K, Mierzwa M, Feng M, Lawrence TS, Cao Y. Quantification of liver function by linearization of a two-compartment model of gadoxetic acid uptake using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed. 2018 06; 31(6):e3913. PMID: 29675932.
      View in: PubMed
    9. Feng M, Valdes G, Dixit N, Solberg TD. Machine Learning in Radiation Oncology: Opportunities, Requirements, and Needs. Front Oncol. 2018; 8:110. PMID: 29719815.
      View in: PubMed
    10. Shilkrut M, Sapir E, Hanasoge S, Schipper MJ, Normolle DP, Ben-Josef E, Ensminger W, Lawrence TS, Feng M. Phase I Trial of Dose-escalated Whole Liver Irradiation With Hepatic Arterial Fluorodeoxyuridine/Leucovorin and Streptozotocin Followed by Fluorodeoxyuridine/Leucovorin and Chemoembolization for Patients With Neuroendocrine Hepatic Metastases. Am J Clin Oncol. 2018 Apr; 41(4):326-331. PMID: 26886946.
      View in: PubMed
    11. Feng M, Suresh K, Schipper MJ, Bazzi L, Ben-Josef E, Matuszak MM, Parikh ND, Welling TH, Normolle D, Ten Haken RK, Lawrence TS. Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage: A Phase 2 Clinical Trial. JAMA Oncol. 2018 Jan 01; 4(1):40-47. PMID: 28796864.
      View in: PubMed
    12. Jackson WC, Tao Y, Mendiratta-Lala M, Bazzi L, Wahl DR, Schipper MJ, Feng M, Cuneo KC, Lawrence TS, Owen D. Comparison of Stereotactic Body Radiation Therapy and Radiofrequency Ablation in the Treatment of Intrahepatic Metastases. Int J Radiat Oncol Biol Phys. 2018 03 15; 100(4):950-958. PMID: 29485074.
      View in: PubMed
    13. Mayo CS, Moran JM, Bosch W, Xiao Y, McNutt T, Popple R, Michalski J, Feng M, Marks LB, Fuller CD, Yorke E, Palta J, Gabriel PE, Molineu A, Matuszak MM, Covington E, Masi K, Richardson SL, Ritter T, Morgas T, Flampouri S, Santanam L, Moore JA, Purdie TG, Miller RC, Hurkmans C, Adams J, Jackie Wu QR, Fox CJ, Siochi RA, Brown NL, Verbakel W, Archambault Y, Chmura SJ, Dekker AL, Eagle DG, Fitzgerald TJ, Hong T, Kapoor R, Lansing B, Jolly S, Napolitano ME, Percy J, Rose MS, Siddiqui S, Schadt C, Simon WE, Straube WL, St James ST, Ulin K, Yom SS, Yock TI. American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology. Int J Radiat Oncol Biol Phys. 2018 03 15; 100(4):1057-1066. PMID: 29485047.
      View in: PubMed
    14. Zhou J, Fang CX, Shen J, Schipper MJ, Zalupski MM, Minter RM, Simeone DM, Hart D, Eagle T, Kimmel GW, Vainshtein J, Lawrence TS, Feng M. Definitive Chemoradiation With Full-dose Gemcitabine for Unresectable Pancreatic Cancer: Efficacy of Involved-Field Radiotherapy. Am J Clin Oncol. 2017 Oct; 40(5):517-522. PMID: 26165418.
      View in: PubMed
    15. Suresh K, Owen D, Bazzi L, Jackson W, Ten Haken RK, Cuneo K, Feng M, Lawrence TS, Schipper MJ. Using Indocyanine Green Extraction to Predict Liver Function After Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys. 2018 01 01; 100(1):131-137. PMID: 29128147.
      View in: PubMed
    16. Sapir E, Tao Y, Schipper MJ, Bazzi L, Novelli PM, Devlin P, Owen D, Cuneo KC, Lawrence TS, Parikh ND, Feng M. Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys. 2018 01 01; 100(1):122-130. PMID: 29066120.
      View in: PubMed
    17. Jackson WC, Dess RT, Litzenberg DW, Li P, Schipper M, Rosenthal SA, Chang GC, Horwitz EM, Price RA, Michalski JM, Gay HA, Wei JT, Feng M, Feng FY, Sandler HM, Wallace RE, Spratt DE, Hamstra DA. A multi-institutional phase 2 trial of prostate stereotactic body radiation therapy (SBRT) using continuous real-time evaluation of prostate motion with patient-reported quality of life. Pract Radiat Oncol. 2018 Jan - Feb; 8(1):40-47. PMID: 29304991.
      View in: PubMed
    18. Pierce LJ, Feng M, Griffith KA, Jagsi R, Boike T, Dryden D, Gustafson GS, Benedetti L, Matuszak MM, Nurushev TS, Haywood J, Radawski JD, Speers C, Walker EM, Hayman JA, Moran JM. Recent Time Trends and Predictors of Heart Dose From Breast Radiation Therapy in a Large Quality Consortium of Radiation Oncology Practices. Int J Radiat Oncol Biol Phys. 2017 12 01; 99(5):1154-1161. PMID: 28927756.
      View in: PubMed
    19. Paximadis P, Schipper M, Matuszak M, Feng M, Jolly S, Boike T, Grills I, Kestin L, Movsas B, Griffith K, Gustafson G, Moran J, Nurushev T, Radawski J, Pierce L, Hayman J. Dosimetric predictors for acute esophagitis during radiation therapy for lung cancer: Results of a large statewide observational study. Pract Radiat Oncol. 2018 May - Jun; 8(3):167-173. PMID: 28919249.
      View in: PubMed
    20. Polan DF, Feng M, Lawrence TS, Ten Haken RK, Brock KK. Implementing Radiation Dose-Volume Liver Response in Biomechanical Deformable Image Registration. Int J Radiat Oncol Biol Phys. 2017 11 15; 99(4):1004-1012. PMID: 28864401.
      View in: PubMed
    21. Bredfeldt JS, Liu L, Feng M, Cao Y, Balter JM. Synthetic CT for MRI-based liver stereotactic body radiotherapy treatment planning. Phys Med Biol. 2017 04 21; 62(8):2922-2934. PMID: 28306547.
      View in: PubMed
    22. Pollom EL, Lee K, Durkee BY, Grade M, Mokhtari DA, Wahl DR, Feng M, Kothary N, Koong AC, Owens DK, Goldhaber-Fiebert J, Chang DT. Cost-effectiveness of Stereotactic Body Radiation Therapy versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Markov Modeling Study. Radiology. 2017 05; 283(2):460-468. PMID: 28045603.
      View in: PubMed
    23. Moran JM, Feng M, Benedetti LA, Marsh R, Griffith KA, Matuszak MM, Hess M, McMullen M, Fisher JH, Nurushev T, Grubb M, Gardner S, Nielsen D, Jagsi R, Hayman JA, Pierce LJ. Development of a model web-based system to support a statewide quality consortium in radiation oncology. Pract Radiat Oncol. 2017 May - Jun; 7(3):e205-e213. PMID: 28196607.
      View in: PubMed
    24. Mayo CS, Kessler ML, Eisbruch A, Weyburne G, Feng M, Hayman JA, Jolly S, El Naqa I, Moran JM, Matuszak MM, Anderson CJ, Holevinski LP, McShan DL, Merkel SM, Machnak SL, Lawrence TS, Ten Haken RK. The big data effort in radiation oncology: Data mining or data farming? Adv Radiat Oncol. 2016 Oct-Dec; 1(4):260-271. PMID: 28740896.
      View in: PubMed
    25. Wu VW, Epelman MA, Wang H, Edwin Romeijn H, Feng M, Cao Y, Ten Haken RK, Matuszak MM. Optimizing global liver function in radiation therapy treatment planning. Phys Med Biol. 2016 09 07; 61(17):6465-84. PMID: 27518786.
      View in: PubMed
    26. Wahl DR, Tao Y, Schipper M, Lawrence TS, Feng M. Reply to Yang et al and De Bari et al. J Clin Oncol. 2016 08 10; 34(23):2799. PMID: 27325853.
      View in: PubMed
    27. Sapir E, Tao Y, Feng F, Samuels S, El Naqa I, Murdoch-Kinch CA, Feng M, Schipper M, Eisbruch A. Predictors of Dysgeusia in Patients With Oropharyngeal Cancer Treated With Chemotherapy and Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016 10 01; 96(2):354-361. PMID: 27473816.
      View in: PubMed
    28. Younge KC, Lee C, Moran JM, Feng M, Novelli P, Prisciandaro JI. Failure mode and effects analysis in a dual-product microsphere brachytherapy environment. Pract Radiat Oncol. 2016 Nov - Dec; 6(6):e299-e306. PMID: 27155761.
      View in: PubMed
    29. Matuszak MM, Hadley SW, Feng M, Hayman JA, Brock KK, Burger P, Owen D, Suresh K, Schipper M, Lawrence TS, Moran JM. Enhancing safety and quality through preplanning peer review for patients undergoing stereotactic body radiation therapy. Pract Radiat Oncol. 2016 Mar-Apr; 6(2):e39-46. PMID: 26746815.
      View in: PubMed
    30. Wahl DR, Stenmark MH, Tao Y, Pollom EL, Caoili EM, Lawrence TS, Schipper MJ, Feng M. Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma. J Clin Oncol. 2016 Feb 10; 34(5):452-9. PMID: 26628466.
      View in: PubMed
    31. Wang H, Feng M, Jackson A, Ten Haken RK, Lawrence TS, Cao Y. Local and Global Function Model of the Liver. Int J Radiat Oncol Biol Phys. 2016 Jan 01; 94(1):181-188. PMID: 26700712.
      View in: PubMed
    32. Jagsi R, Griffith KA, Boike TP, Walker E, Nurushev T, Grills IS, Moran JM, Feng M, Hayman J, Pierce LJ. Differences in the Acute Toxic Effects of Breast Radiotherapy by Fractionation Schedule: Comparative Analysis of Physician-Assessed and Patient-Reported Outcomes in a Large Multicenter Cohort. JAMA Oncol. 2015 Oct; 1(7):918-30. PMID: 26247417.
      View in: PubMed
    33. Paradis E, Cao Y, Lawrence TS, Tsien C, Feng M, Vineberg K, Balter JM. Assessing the Dosimetric Accuracy of Magnetic Resonance-Generated Synthetic CT Images for Focal Brain VMAT Radiation Therapy. Int J Radiat Oncol Biol Phys. 2015 Dec 01; 93(5):1154-61. PMID: 26581151; PMCID: PMC4654706 [Available on 12/01/16].
    34. Feng M, Brunner TB, Ben-Josef E. Stereotactic Body Radiation Therapy for Liver Cancer: Effective Therapy With Minimal Impact on Quality of Life. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):26-8. PMID: 26279021.
      View in: PubMed
    35. Davis EJ, Chugh R, Zhao L, Lucas DR, Biermann JS, Zalupski MM, Feng M, Wong SL, Jacobson J, Zyczynski L, Reinke D, Metko G, Baker LH, Schuetze SM. A randomised, open-label, phase II study of neo/adjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcoma. Eur J Cancer. 2015 Sep; 51(13):1794-802. PMID: 26066736.
      View in: PubMed
    36. Hsu SH, Cao Y, Lawrence TS, Tsien C, Feng M, Grodzki DM, Balter JM. Quantitative characterizations of ultrashort echo (UTE) images for supporting air-bone separation in the head. Phys Med Biol. 2015 Apr 07; 60(7):2869-80. PMID: 25776205; PMCID: PMC4405190.
    37. Shumway DA, Griffith KA, Pierce LJ, Feng M, Moran JM, Stenmark MH, Jagsi R, Hayman JA. Wide Variation in the Diffusion of a New Technology: Practice-Based Trends in Intensity-Modulated Radiation Therapy (IMRT) Use in the State of Michigan, With Implications for IMRT Use Nationally. J Oncol Pract. 2015 May; 11(3):e373-9. PMID: 25736383.
      View in: PubMed
    38. Siegel GW, Biermann JS, Chugh R, Jacobson JA, Lucas D, Feng M, Chang AC, Smith SR, Wong SL, Hasen J. The multidisciplinary management of bone and soft tissue sarcoma: an essential organizational framework. J Multidiscip Healthc. 2015; 8:109-15. PMID: 25733913; PMCID: PMC4340372.
    39. Jagsi R, Griffith KA, Heimburger D, Walker EM, Grills IS, Boike T, Feng M, Moran JM, Hayman J, Pierce LJ. Choosing wisely? Patterns and correlates of the use of hypofractionated whole-breast radiation therapy in the state of Michigan. Int J Radiat Oncol Biol Phys. 2014 Dec 01; 90(5):1010-6. PMID: 25539366.
      View in: PubMed
    40. Cuneo KC, Chenevert TL, Ben-Josef E, Feng MU, Greenson JK, Hussain HK, Simeone DM, Schipper MJ, Anderson MA, Zalupski MM, Al-Hawary M, Galban CJ, Rehemtulla A, Feng FY, Lawrence TS, Ross BD. A pilot study of diffusion-weighted MRI in patients undergoing neoadjuvant chemoradiation for pancreatic cancer. Transl Oncol. 2014 Oct; 7(5):644-9. PMID: 25389460; PMCID: PMC4225651.
    41. Feng M, Pierce LJ. Getting to the heart of the matter. J Natl Cancer Inst. 2014 Aug; 106(8). PMID: 25128696.
      View in: PubMed
    42. Tempero MA, Malafa MP, Behrman SW, Benson AB, Casper ES, Chiorean EG, Chung V, Cohen SJ, Czito B, Engebretson A, Feng M, Hawkins WG, Herman J, Hoffman JP, Ko A, Komanduri S, Koong A, Lowy AM, Ma WW, Merchant NB, Mulvihill SJ, Muscarella P, Nakakura EK, Obando J, Pitman MB, Reddy S, Sasson AR, Thayer SP, Weekes CD, Wolff RA, Wolpin BM, Burns JL, Freedman-Cass DA. Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2014 Aug; 12(8):1083-93. PMID: 25099441.
      View in: PubMed
    43. Tran LK, Maturen KE, Feng MU, Wizauer EJ, Watcharotone K, Parker RA, Ellis JH. Renal remodeling after abdominal radiation therapy: parenchymal and functional changes. AJR Am J Roentgenol. 2014 Aug; 203(2):W192-8. PMID: 25055293.
      View in: PubMed
    44. Hong TS, Bosch WR, Krishnan S, Kim TK, Mamon HJ, Shyn P, Ben-Josef E, Seong J, Haddock MG, Cheng JC, Feng MU, Stephans KL, Roberge D, Crane C, Dawson LA. Interobserver variability in target definition for hepatocellular carcinoma with and without portal vein thrombus: radiation therapy oncology group consensus guidelines. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):804-13. PMID: 24969794; PMCID: PMC4285340.
    45. Cuneo KC, Davis MA, Feng MU, Novelli PM, Ensminger WD, Lawrence TS. Low dose rate radiosensitization of hepatocellular carcinoma in vitro and in patients. Transl Oncol. 2014 Aug; 7(4):472-8. PMID: 24956939.
      View in: PubMed
    46. Stenmark MH, Cao Y, Wang H, Jackson A, Ben-Josef E, Ten Haken RK, Lawrence TS, Feng M. Estimating functional liver reserve following hepatic irradiation: adaptive normal tissue response models. Radiother Oncol. 2014 Jun; 111(3):418-23. PMID: 24813090.
      View in: PubMed
    47. Wang H, Farjam R, Feng M, Hussain H, Ten Haken RK, Lawrence TS, Cao Y. Arterial perfusion imaging-defined subvolume of intrahepatic cancer. Int J Radiat Oncol Biol Phys. 2014 May 01; 89(1):167-74. PMID: 24613814; PMCID: PMC3988211.
    48. Welling TH, Feng M, Wan S, Hwang SY, Volk ML, Lawrence TS, Zalupski MM, Sonnenday CJ. Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma. Liver Transpl. 2014 Jan; 20(1):81-8. PMID: 24115315; PMCID: PMC4185427.
    49. Hsu SH, Cao Y, Huang K, Feng M, Balter JM. Investigation of a method for generating synthetic CT models from MRI scans of the head and neck for radiation therapy. Phys Med Biol. 2013 Dec 07; 58(23):8419-35. PMID: 24217183; PMCID: PMC3886820.
    50. Hunter KU, Fernandes LL, Vineberg KA, McShan D, Antonuk AE, Cornwall C, Feng M, Schipper MJ, Balter JM, Eisbruch A. Parotid glands dose-effect relationships based on their actually delivered doses: implications for adaptive replanning in radiation therapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2013 Nov 15; 87(4):676-82. PMID: 24035328; PMCID: PMC3805710.
    51. Liu E, Stenmark MH, Schipper MJ, Balter JM, Kessler ML, Caoili EM, Lee OE, Ben-Josef E, Lawrence TS, Feng M. Stereotactic body radiation therapy for primary and metastatic liver tumors. Transl Oncol. 2013 Aug; 6(4):442-6. PMID: 23908687; PMCID: PMC3730019.
    52. Wilkie JR, Matuszak MM, Feng M, Moran JM, Fraass BA. Use of plan quality degradation to evaluate tradeoffs in delivery efficiency and clinical plan metrics arising from IMRT optimizer and sequencer compromises. Med Phys. 2013 Jul; 40(7):071708. PMID: 23822412; PMCID: PMC3695972.
    53. Wang H, Feng M, Frey KA, Ten Haken RK, Lawrence TS, Cao Y. Predictive models for regional hepatic function based on 99mTc-IDA SPECT and local radiation dose for physiologic adaptive radiation therapy. Int J Radiat Oncol Biol Phys. 2013 Aug 01; 86(5):1000-6. PMID: 23688813.
      View in: PubMed
    54. Wang H, Feng M, Frey K, Balter J, Haken RT, Lawrence T, Cao Y. Hepatic Function Model Based Upon HIDA SPECT and Dose for Physiological Adaptive RT. Pract Radiat Oncol. 2013 Apr-Jun; 3(2 Suppl 1):S2. PMID: 24674506.
      View in: PubMed
    55. Tran LK, Maturen KE, Feng MU, Wizauer E, Watcharotone K, Ellis JH. Renal remodeling in the first 24 months after abdominal radiotherapy. Pract Radiat Oncol. 2013 Apr-Jun; 3(2 Suppl 1):S6. PMID: 24674564.
      View in: PubMed
    56. Maturen KE, Feng MU, Wasnik AP, Azar SF, Appelman HD, Francis IR, Platt JF. Imaging effects of radiation therapy in the abdomen and pelvis: evaluating "innocent bystander" tissues. Radiographics. 2013 Mar-Apr; 33(2):599-619. PMID: 23479716.
      View in: PubMed
    57. Chung E, Corbett JR, Moran JM, Griffith KA, Marsh RB, Feng M, Jagsi R, Kessler ML, Ficaro EC, Pierce LJ. Is there a dose-response relationship for heart disease with low-dose radiation therapy? Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85(4):959-64. PMID: 23021709.
      View in: PubMed
    58. Long T, Matuszak M, Feng M, Fraass BA, Ten Haken RK, Romeijn HE. Sensitivity analysis for lexicographic ordering in radiation therapy treatment planning. Med Phys. 2012 Jun; 39(6):3445-55. PMID: 22755724; PMCID: PMC3371080.
    59. Feng M, Demiroz C, Vineberg KA, Eisbruch A, Balter JM. Normal tissue anatomy for oropharyngeal cancer: contouring variability and its impact on optimization. Int J Radiat Oncol Biol Phys. 2012 Oct 01; 84(2):e245-9. PMID: 22583602; PMCID: PMC3432166.
    60. Feng M, Normolle D, Pan CC, Dawson LA, Amarnath S, Ensminger WD, Lawrence TS, Ten Haken RK. Dosimetric analysis of radiation-induced gastric bleeding. Int J Radiat Oncol Biol Phys. 2012 Sep 01; 84(1):e1-6. PMID: 22541965; PMCID: PMC3423508.
    61. Cao Y, Wang H, Johnson TD, Pan C, Hussain H, Balter JM, Normolle D, Ben-Josef E, Ten Haken RK, Lawrence TS, Feng M. Prediction of liver function by using magnetic resonance-based portal venous perfusion imaging. Int J Radiat Oncol Biol Phys. 2013 Jan 01; 85(1):258-63. PMID: 22520476; PMCID: PMC3629546.
    62. Sabolch A, Feng M, Griffith K, Rzasa C, Gadzala L, Feng F, Biermann JS, Chugh R, Ray M, Ben-Josef E. Risk factors for local recurrence and metastasis in soft tissue sarcomas of the extremity. Am J Clin Oncol. 2012 Apr; 35(2):151-7. PMID: 21336091.
      View in: PubMed
    63. Feng M, Smith DE, Normolle DP, Knol JA, Pan CC, Ben-Josef E, Lu Z, Feng MR, Chen J, Ensminger W, Lawrence TS. A phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapy. Int J Radiat Oncol Biol Phys. 2012 Aug 01; 83(5):1441-7. PMID: 22440042; PMCID: PMC3383372.
    64. Rubin JM, Feng M, Hadley SW, Fowlkes JB, Hamilton JD. Potential use of ultrasound speckle tracking for motion management during radiotherapy: preliminary report. J Ultrasound Med. 2012 Mar; 31(3):469-81. PMID: 22368138.
      View in: PubMed
    65. Woods DR, Davison A, Stacey M, Smith C, Hooper T, Neely D, Turner S, Peaston R, Mellor A. The cortisol response to hypobaric hypoxia at rest and post-exercise. Horm Metab Res. 2012 Apr; 44(4):302-5. PMID: 22368038.
      View in: PubMed
    66. Stenmark MH, Vineberg K, Ten Haken RK, Hamstra DA, Feng M. Dosimetric implications of residual seminal vesicle motion in fiducial-guided intensity-modulated radiotherapy for prostate cancer. Med Dosim. 2012; 37(3):240-4. PMID: 22189029.
      View in: PubMed
    67. Pak D, Vineberg KA, Griffith KA, Sabolch A, Chugh R, Ben-Josef E, Biermann JS, Feng M. Dose--effect relationships for femoral fractures after multimodality limb-sparing therapy of soft-tissue sarcomas of the proximal lower extremity. Int J Radiat Oncol Biol Phys. 2012 Jul 15; 83(4):1257-63. PMID: 22099042.
      View in: PubMed
    68. Feng M, Ben-Josef E. Radiation therapy for hepatocellular carcinoma. Semin Radiat Oncol. 2011 Oct; 21(4):271-7. PMID: 21939856.
      View in: PubMed
    69. Sabolch A, Feng M, Griffith K, Hammer G, Doherty G, Ben-Josef E. Adjuvant and definitive radiotherapy for adrenocortical carcinoma. Int J Radiat Oncol Biol Phys. 2011 Aug 01; 80(5):1477-84. PMID: 20675074.
      View in: PubMed
    70. Feng FY, Kim HM, Lyden TH, Haxer MJ, Worden FP, Feng M, Moyer JS, Prince ME, Carey TE, Wolf GT, Bradford CR, Chepeha DB, Eisbruch A. Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. J Clin Oncol. 2010 Jun 01; 28(16):2732-8. PMID: 20421546; PMCID: PMC2881852.
    71. Feng M, Moran JM, Koelling T, Chughtai A, Chan JL, Freedman L, Hayman JA, Jagsi R, Jolly S, Larouere J, Soriano J, Marsh R, Pierce LJ. Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys. 2011 Jan 01; 79(1):10-8. PMID: 20421148; PMCID: PMC2937165.
    72. McLaughlin PW, Evans C, Feng M, Narayana V. Radiographic and anatomic basis for prostate contouring errors and methods to improve prostate contouring accuracy. Int J Radiat Oncol Biol Phys. 2010 Feb 01; 76(2):369-78. PMID: 19515511.
      View in: PubMed
    73. Feng M, Balter JM, Normolle D, Adusumilli S, Cao Y, Chenevert TL, Ben-Josef E. Characterization of pancreatic tumor motion using cine MRI: surrogates for tumor position should be used with caution. Int J Radiat Oncol Biol Phys. 2009 Jul 01; 74(3):884-91. PMID: 19395190; PMCID: PMC2691867.
    74. Feng M, Kong FM, Gross M, Fernando S, Hayman JA, Ten Haken RK. Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing. Int J Radiat Oncol Biol Phys. 2009 Mar 15; 73(4):1228-34. PMID: 19251094; PMCID: PMC3381895.
    75. Feng FY, Kim HM, Lyden TH, Haxer MJ, Feng M, Worden FP, Chepeha DB, Eisbruch A. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys. 2007 Aug 01; 68(5):1289-98. PMID: 17560051.
      View in: PubMed
    76. Feng M, Murphy J, Griffith KA, Baker LH, Sondak VK, Lucas DR, McGinn CJ, Ray ME. Long-term outcomes after radiotherapy for retroperitoneal and deep truncal sarcoma. Int J Radiat Oncol Biol Phys. 2007 Sep 01; 69(1):103-10. PMID: 17560050.
      View in: PubMed
    77. Feng M, Hanlon AL, Pisansky TM, Kuban D, Catton CN, Michalski JM, Zelefsky MJ, Kupelian PA, Pollack A, Kestin LL, Valicenti RK, DeWeese TL, Sandler HM. Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy. Int J Radiat Oncol Biol Phys. 2007 Aug 01; 68(5):1417-23. PMID: 17418972.
      View in: PubMed
    78. Feng M, Eisbruch A. Future issues in highly conformal radiotherapy for head and neck cancer. J Clin Oncol. 2007 Mar 10; 25(8):1009-13. PMID: 17350951.
      View in: PubMed
    79. Feng M, Ben-Josef E. Adjuvant therapy for pancreatic cancer: the glass is half empty. Nat Clin Pract Oncol. 2007 Mar; 4(3):148-9. PMID: 17245345.
      View in: PubMed
    80. Jabbari S, Kim HM, Feng M, Lin A, Tsien C, Elshaikh M, Terrel JE, Murdoch-Kinch C, Eisbruch A. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report. Int J Radiat Oncol Biol Phys. 2005 Nov 01; 63(3):725-31. PMID: 16199308.
      View in: PubMed
    81. Feng M, Jabbari S, Lin A, Bradford CR, Chepeha DB, Teknos TN, Worden FP, Tsien C, Schipper MJ, Wolf GT, Dawson LA, Eisbruch A. Predictive factors of local-regional recurrences following parotid sparing intensity modulated or 3D conformal radiotherapy for head and neck cancer. Radiother Oncol. 2005 Oct; 77(1):32-8. PMID: 16154219.
      View in: PubMed